Atossa Therapeutics
ATOS
ATOS
14 hedge funds and large institutions have $649K invested in Atossa Therapeutics in 2019 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Holders
14
Holding in Top 10
–
Calls
$43K
Puts
–
Top Buyers
| 1 | +$137K | |
| 2 | +$114K | |
| 3 | +$27.5K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$6.01K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$801 |
Top Sellers
| 1 | -$240K | |
| 2 | -$128K | |
| 3 | -$92K | |
| 4 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$13.3K |
| 5 |
Barclays
London,
United Kingdom
|
-$4.49K |